Boeing vs. Joby Aviation: Which Airplane Manufacturing Stock Promises High-Flying Profits?

Boeing returned to profitability with FY2025 revenue of ~$89.5B (+34.5% YoY) and net income of ~$2.2B (net margin ~2.5%), but free cash flow was still negative at ~-$1.9B with SBC inflating cash generation. Joby Aviation showed explosive revenue growth to ~$53.4M (from ~$136k in 2024) yet still posted a net loss of ~-$930M and free cash flow of ~-$563.8M as it pursues FAA certification and commercialization. The article frames the choice as a recovering, highly levered aerospace incumbent (debt-to-equity ~10x) versus a debt-free but speculative eVTOL bet (forward P/S ~26.1x vs Boeing ~1.8x).

Analysis

The market is likely to keep rewarding the names with verifiable cash conversion and punishing the ones whose value depends on certification optionality. That makes BA a slow-burn recovery story rather than a clean quality compounder: if production normalizes, the equity can re-rate, but leverage and weak free cash flow cap how much the market will pay for the upside. The more interesting second-order winner is SPR, because sustained build-rate improvement and any cleaner integration path should show up there before it is fully reflected in BA.

JOBY is a duration asset, but the equity still trades like a financing instrument until certification and fleet economics become observable. The key risk is not technological failure; it is dilution before revenue scales, especially if execution slips by even one FAA milestone cycle. That means the downside can stay compressed for months, then gap lower on a raise or a delayed approval, while the upside only becomes durable if regulators move from permissive testing to commercial sign-off.

Consensus is probably underestimating how little near-term earnings power matters for JOBY and overestimating how much of BA’s recovery is already monetizable at the stock level. The real debate is not "recovery vs disruption" but "cash generation now vs funded growth later." For the next 1-3 months, the cleaner expression is relative-value rather than outright beta: prefer exposure to execution over story, and be ready to fade any eVTOL rally that is not backed by a financing or certification update.

Key Decisions for Investors

• Long BA / short JOBY for 3-6 months: use this as a relative-value expression that favors cash-flow recovery over multi-year optionality. Entry on JOBY strength or BA pullbacks; thesis breaks if BA misses delivery cadence or JOBY gets an FAA production-type approval plus clear funding runway.
• Avoid naked long JOBY common into the next certification cycle; if exposure is desired, use a small call spread only after confirming the company has enough cash to avoid near-term dilution. The key risk is a financing event, not operational bankruptcy.
• Watch SPR as the highest-beta beneficiary of a real Boeing production recovery. If 737/787 throughput improves for two consecutive quarters, SPR can rerate faster than BA because suppliers reprice margin leverage before OEM equity does.
• Use DAL as a secondary beneficiary, not a direct trade, unless aircraft delivery constraints ease materially. Better aircraft availability supports capacity growth and fleet efficiency, but this is a slower earnings transmission than the OEM/supplier trade.